133 related articles for article (PubMed ID: 28673556)
1. Exome sequencing identifies targets in the treatment-resistant ophthalmoplegic subphenotype of myasthenia gravis.
Nel M; Jalali Sefid Dashti M; Gamieldien J; Heckmann JM
Neuromuscul Disord; 2017 Sep; 27(9):816-825. PubMed ID: 28673556
[TBL] [Abstract][Full Text] [Related]
2. A unique subphenotype of myasthenia gravis.
Heckmann JM; Nel M
Ann N Y Acad Sci; 2018 Jan; 1412(1):14-20. PubMed ID: 28984362
[TBL] [Abstract][Full Text] [Related]
3. Profiling of patient-specific myocytes identifies altered gene expression in the ophthalmoplegic subphenotype of myasthenia gravis.
Nel M; Prince S; Heckmann JM
Orphanet J Rare Dis; 2019 Jan; 14(1):24. PubMed ID: 30696470
[TBL] [Abstract][Full Text] [Related]
4. Using Whole Genome Sequencing in an African Subphenotype of Myasthenia Gravis to Generate a Pathogenetic Hypothesis.
Nel M; Mulder N; Europa TA; Heckmann JM
Front Genet; 2019; 10():136. PubMed ID: 30881381
[TBL] [Abstract][Full Text] [Related]
5. The African-387 C>T TGFB1 variant is functional and associates with the ophthalmoplegic complication in juvenile myasthenia gravis.
Nel M; Buys JM; Rautenbach R; Mowla S; Prince S; Heckmann JM
J Hum Genet; 2016 Apr; 61(4):307-16. PubMed ID: 26632886
[TBL] [Abstract][Full Text] [Related]
6. Gene expression profiling of orbital muscles in treatment-resistant ophthalmoplegic myasthenia gravis.
Europa TA; Nel M; Heckmann JM
Orphanet J Rare Dis; 2020 Dec; 15(1):346. PubMed ID: 33308266
[TBL] [Abstract][Full Text] [Related]
7. Whole-exome sequencing reveals a rare interferon gamma receptor 1 mutation associated with myasthenia gravis.
Qi G; Liu P; Gu S; Yang H; Dong H; Xue Y
Neurol Sci; 2018 Apr; 39(4):717-724. PubMed ID: 29441481
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial bioenergetics in ocular fibroblasts of two myasthenia gravis cases.
Europa TA; Nel M; Lebeko MR; Heckmann JM
IBRO Neurosci Rep; 2022 Jun; 12():297-302. PubMed ID: 35746973
[TBL] [Abstract][Full Text] [Related]
9. Myasthenia gravis and associated autoimmune diseases in children.
Tsao CY; Mendell JR; Lo WD; Luquette M; Rennebohm R
J Child Neurol; 2000 Nov; 15(11):767-9. PubMed ID: 11108515
[TBL] [Abstract][Full Text] [Related]
10. A genome-wide association study of myasthenia gravis.
Renton AE; Pliner HA; Provenzano C; Evoli A; Ricciardi R; Nalls MA; Marangi G; Abramzon Y; Arepalli S; Chong S; Hernandez DG; Johnson JO; Bartoccioni E; Scuderi F; Maestri M; Gibbs JR; Errichiello E; Chiò A; Restagno G; Sabatelli M; Macek M; Scholz SW; Corse A; Chaudhry V; Benatar M; Barohn RJ; McVey A; Pasnoor M; Dimachkie MM; Rowin J; Kissel J; Freimer M; Kaminski HJ; Sanders DB; Lipscomb B; Massey JM; Chopra M; Howard JF; Koopman WJ; Nicolle MW; Pascuzzi RM; Pestronk A; Wulf C; Florence J; Blackmore D; Soloway A; Siddiqi Z; Muppidi S; Wolfe G; Richman D; Mezei MM; Jiwa T; Oger J; Drachman DB; Traynor BJ
JAMA Neurol; 2015 Apr; 72(4):396-404. PubMed ID: 25643325
[TBL] [Abstract][Full Text] [Related]
11. A review of the histopathological findings in myasthenia gravis: Clues to the pathogenesis of treatment-resistance in extraocular muscles.
Europa TA; Nel M; Heckmann JM
Neuromuscul Disord; 2019 May; 29(5):381-387. PubMed ID: 31029532
[TBL] [Abstract][Full Text] [Related]
12. Involvement of human muscle acetylcholine receptor alpha-subunit gene (CHRNA) in susceptibility to myasthenia gravis.
Garchon HJ; Djabiri F; Viard JP; Gajdos P; Bach JF
Proc Natl Acad Sci U S A; 1994 May; 91(11):4668-72. PubMed ID: 7910962
[TBL] [Abstract][Full Text] [Related]
13. Association of transforming growth factor β-1 (TGFB1) regulatory region polymorphisms with myasthenia gravis-related ophthalmoparesis.
Akinyi MV; Dandara C; Gamieldien J; Heckmann JM
J Neuroimmunol; 2012 May; 246(1-2):96-9. PubMed ID: 22458981
[TBL] [Abstract][Full Text] [Related]
14. The Epidemiology and Phenotypes of Ocular Manifestations in Childhood and Juvenile Myasthenia Gravis: A Review.
Heckmann JM; Europa TA; Soni AJ; Nel M
Front Neurol; 2022; 13():834212. PubMed ID: 35280301
[TBL] [Abstract][Full Text] [Related]
15. The natural history and ophthalmic involvement in childhood myasthenia gravis at the hospital for sick children.
Mullaney P; Vajsar J; Smith R; Buncic JR
Ophthalmology; 2000 Mar; 107(3):504-10. PubMed ID: 10711889
[TBL] [Abstract][Full Text] [Related]
16. Childhood myasthenia gravis.
Berkovitz S; Belkin M; Tenenbaum A
J Pediatr Ophthalmol; 1977; 14(5):269-73. PubMed ID: 925839
[TBL] [Abstract][Full Text] [Related]
17. A genetic study of infantile and juvenile myasthenia gravis.
Bundey S
J Neurol Neurosurg Psychiatry; 1972 Feb; 35(1):41-51. PubMed ID: 5026010
[TBL] [Abstract][Full Text] [Related]
18. "Mummy, my eyelids are heavy": A case series of juvenile myasthenia gravis.
Krishna L; Abdul Jalil NF; Lott PW; Singh S; Choo MM
Eur J Ophthalmol; 2021 Mar; 31(2):NP119-NP122. PubMed ID: 31390886
[TBL] [Abstract][Full Text] [Related]
19. Myasthenia gravis in South Africans: racial differences in clinical manifestations.
Heckmann JM; Owen EP; Little F
Neuromuscul Disord; 2007 Dec; 17(11-12):929-34. PubMed ID: 17720497
[TBL] [Abstract][Full Text] [Related]
20. Major review: the clinical spectrum of pediatric myasthenia gravis: blepharoptosis, ophthalmoplegia and strabismus. A report of 14 cases.
McCreery KM; Hussein MA; Lee AG; Paysse EA; Chandran R; Coats DK
Binocul Vis Strabismus Q; 2002; 17(3):181-6. PubMed ID: 12171588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
